We sought to verify whether S100A9 and S100A8 / 9 effects are blocked with specific antibodies, using rabbit polyclonal antibodies raised against human S100A8 or S100A9.	"S100A9	28	34	Gene/Protein"	"S100A8	39	45	Gene/Protein"	"antibodies	84	94	Gene/Protein"	"rabbit	102	108	Organism/Species"	"antibodies	120	130	Gene/Protein"	"human	146	151	Organism/Species"	"S100A8	152	158	Gene/Protein"	"S100A9	162	168	Gene/Protein"	"[{""token"": ""S100A9"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""S100A8"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 84, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Organism/Species""}, {""token"": ""antibodies"", ""start_span"": 120, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""S100A8"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""S100A9"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Gene/Protein""}]"
For all experiments, the mice were of the C57B6 / J strain. Jmjd2b floxed mice, in which exon 5 of the Jmjd2b allele was flanked by loxP sequences bilaterally, 13 were crossed with mice expressing Cre recombinase under the control of the Tau promoter, 21 resulting in the specific deletion of JMJD2B in neurons.	"mice	25	29	Organism/Species"	"Jmjd2b	60	66	Gene/Protein"	"mice	74	78	Organism/Species"	"Jmjd2b	103	109	Gene/Protein"	"mice	181	185	Organism/Species"	"Cre recombinase	197	212	Gene/Protein"	"Tau	238	241	Gene/Protein"	"JMJD2B	293	299	Gene/Protein"	"[{""token"": ""mice"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Organism/Species""}, {""token"": ""Jmjd2b"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""Jmjd2b"", ""start_span"": 103, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 181, ""end_span"": 185, ""type"": ""Organism/Species""}, {""token"": ""Cre recombinase"", ""start_span"": 197, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""Tau"", ""start_span"": 238, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""JMJD2B"", ""start_span"": 293, ""end_span"": 299, ""type"": ""Gene/Protein""}]"
A previous report suggests that JMJD2B is a causative risk gene for neurodevelopmental disorders, 8 while accumulating evidence indicates that hippocampal spines in various mouse models of neurodevelopmental disorder are structurally and functionally abnormal. 36, 37, 38, 39 For example, mice with a mutation in SHANK2, a risk gene for ASD, display an increased number of hippocampal spines and abnormal synaptic transmission in the hippocampus. 37 Furthermore, high - density and spindle - shaped dendritic spines are also observed in the brains of individuals with neurodevelopmental disorders. 40	"JMJD2B	32	38	Gene/Protein"	"neurodevelopmental disorders	68	96	Disease/Disorder"	"mouse	173	178	Organism/Species"	"neurodevelopmental disorder	189	216	Disease/Disorder"	"mice	289	293	Organism/Species"	"SHANK2	313	319	Gene/Protein"	"ASD	337	340	Disease/Disorder"	"neurodevelopmental disorders	568	596	Disease/Disorder"	"[{""token"": ""JMJD2B"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""neurodevelopmental disorders"", ""start_span"": 68, ""end_span"": 96, ""type"": ""Disease/Disorder""}, {""token"": ""mouse"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Organism/Species""}, {""token"": ""neurodevelopmental disorder"", ""start_span"": 189, ""end_span"": 216, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 289, ""end_span"": 293, ""type"": ""Organism/Species""}, {""token"": ""SHANK2"", ""start_span"": 313, ""end_span"": 319, ""type"": ""Gene/Protein""}, {""token"": ""ASD"", ""start_span"": 337, ""end_span"": 340, ""type"": ""Disease/Disorder""}, {""token"": ""neurodevelopmental disorders"", ""start_span"": 568, ""end_span"": 596, ""type"": ""Disease/Disorder""}]"
For example, several mouse models with mutated risk genes for ASD display abnormalities in ultrasonic vocalization, and this important behavioral characteristic in ASD - model mice was not tested in our study. 41, 42 Although rearing behavior in mice is generally described as an index of exploratory behavior, increases in the frequency of rearing number observed in JMJD2B mutant mice may replicate repetitive behavior in ASD.	"mouse	21	26	Organism/Species"	"ASD	62	65	Disease/Disorder"	"ASD	164	167	Disease/Disorder"	"mice	176	180	Organism/Species"	"mice	246	250	Organism/Species"	"JMJD2B	368	374	Gene/Protein"	"mice	382	386	Organism/Species"	"ASD	424	427	Disease/Disorder"	"[{""token"": ""mouse"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Organism/Species""}, {""token"": ""ASD"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Disease/Disorder""}, {""token"": ""ASD"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 246, ""end_span"": 250, ""type"": ""Organism/Species""}, {""token"": ""JMJD2B"", ""start_span"": 368, ""end_span"": 374, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 382, ""end_span"": 386, ""type"": ""Organism/Species""}, {""token"": ""ASD"", ""start_span"": 424, ""end_span"": 427, ""type"": ""Disease/Disorder""}]"
Myelin - oligodendrocyte - glycoprotein ( MOG )- induced experimental autoimmune encephalomyelitis ( EAE) is an animal model of multiple sclerosis ( MS ), a chronic autoimmune disease of the CNS that results in disability.	"Myelin - oligodendrocyte - glycoprotein	0	39	Gene/Protein"	"MOG	42	45	Gene/Protein"	"experimental autoimmune encephalomyelitis	57	98	Disease/Disorder"	"EAE	101	104	Disease/Disorder"	"animal	112	118	Organism/Species"	"multiple sclerosis	128	146	Disease/Disorder"	"MS	149	151	Disease/Disorder"	"chronic autoimmune disease	157	183	Disease/Disorder"	"[{""token"": ""Myelin - oligodendrocyte - glycoprotein"", ""start_span"": 0, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""MOG"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""experimental autoimmune encephalomyelitis"", ""start_span"": 57, ""end_span"": 98, ""type"": ""Disease/Disorder""}, {""token"": ""EAE"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Disease/Disorder""}, {""token"": ""animal"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""multiple sclerosis"", ""start_span"": 128, ""end_span"": 146, ""type"": ""Disease/Disorder""}, {""token"": ""MS"", ""start_span"": 149, ""end_span"": 151, ""type"": ""Disease/Disorder""}, {""token"": ""chronic autoimmune disease"", ""start_span"": 157, ""end_span"": 183, ""type"": ""Disease/Disorder""}]"
Here, we show involvement of Cd38, Cxcr4 and Akt and confirm these findings by the use of Cd38 - knockout ( B6. 129P2 - Cd38tm1Lnd / J) mice, S1P - receptor modulation during EAE and quantitative expression analysis in individuals with MS.	"Cd38	29	33	Gene/Protein"	"Cxcr4	35	40	Gene/Protein"	"Akt	45	48	Gene/Protein"	"Cd38	90	94	Gene/Protein"	"mice	136	140	Organism/Species"	"S1P - receptor	142	156	Gene/Protein"	"EAE	175	178	Disease/Disorder"	"MS	236	238	Disease/Disorder"	"[{""token"": ""Cd38"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""Cxcr4"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Akt"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""Cd38"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Organism/Species""}, {""token"": ""S1P - receptor"", ""start_span"": 142, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""EAE"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Disease/Disorder""}, {""token"": ""MS"", ""start_span"": 236, ""end_span"": 238, ""type"": ""Disease/Disorder""}]"
Then, plates were washed and rabbit anti - mouse antiserum ( IgG, IgG1, IgG2a, IgG2b, IgG3, IgM; Nordic, Tilburg, The Netherlands) was added and incubated for 1 h at room temperature.	"rabbit	29	35	Organism/Species"	"mouse	43	48	Organism/Species"	"IgG	61	64	Gene/Protein"	"IgG1	66	70	Gene/Protein"	"IgG2a	72	77	Gene/Protein"	"IgG2b	79	84	Gene/Protein"	"IgG3	86	90	Gene/Protein"	"IgM	92	95	Gene/Protein"	"[{""token"": ""rabbit"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""IgG1"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""IgG2a"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IgG2b"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""IgG3"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""IgM"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}]"
Shown is an expression profiling by RT - qPCR analysis of Puf1, Puf2, UIS1 / IK2, UIS4 and HSP70 mRNA levels in WT, puf1 (-) and puf2 (-) P. berghei sporozoites.	"Puf1	58	62	Gene/Protein"	"Puf2	64	68	Gene/Protein"	"UIS1	70	74	Gene/Protein"	"IK2	77	80	Gene/Protein"	"UIS4	82	86	Gene/Protein"	"HSP70	91	96	Gene/Protein"	"puf1	116	120	Gene/Protein"	"puf2	129	133	Gene/Protein"	"[{""token"": ""Puf1"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Puf2"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""UIS1"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""IK2"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""UIS4"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""HSP70"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""puf1"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""puf2"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}]"
Stable clones were selected in DMEM containing 10% horse serum ( MP Biomedicals, France ), 5% tetracycline - screened fetal bovine serum ( Thermo Scientific “ HyClone ”, Belgium ), penicillin, streptomycin, l - glutamine, 100 mg · mL − 1 G418, and 2 mg · mL − 1 puromycin, at 37 ° C and 5% CO2.	"horse	51	56	Organism/Species"	"tetracycline	94	106	Chemical/Drug"	"bovine	124	130	Organism/Species"	"penicillin	181	191	Chemical/Drug"	"streptomycin	193	205	Chemical/Drug"	"l - glutamine	207	220	Chemical/Drug"	"G418	238	242	Chemical/Drug"	"puromycin	262	271	Chemical/Drug"	"[{""token"": ""horse"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism/Species""}, {""token"": ""tetracycline"", ""start_span"": 94, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""bovine"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Organism/Species""}, {""token"": ""penicillin"", ""start_span"": 181, ""end_span"": 191, ""type"": ""Chemical/Drug""}, {""token"": ""streptomycin"", ""start_span"": 193, ""end_span"": 205, ""type"": ""Chemical/Drug""}, {""token"": ""l - glutamine"", ""start_span"": 207, ""end_span"": 220, ""type"": ""Chemical/Drug""}, {""token"": ""G418"", ""start_span"": 238, ""end_span"": 242, ""type"": ""Chemical/Drug""}, {""token"": ""puromycin"", ""start_span"": 262, ""end_span"": 271, ""type"": ""Chemical/Drug""}]"
The neuroblastoma cell lines CLB - GA ( 1p deletion, 11q deletion, 17q gain, ALKR1275Q mutation ), CLB - GE ( MYCN / ALK - amplified, ALKF1174V mutation, 1p deletion, 17q gain ), CLB - BAR ( amplified MYCN / ALKΔexon 4 – 12, 1p deletion, 17q gain) and Kelly ( MYCN - amplified, ALKF1174L mutation) were maintained in RPMI - 1640 medium supplemented with 10% fetal bovine serum ( Sigma, Stockholm, Sweden ), 100 U · mL − 1 penicillin, and 100 μg · mL − 1 streptomycin, at 37 ° C in humidified air with 5% CO2 38 – 40.	"neuroblastoma	4	17	Disease/Disorder"	"MYCN	110	114	Gene/Protein"	"ALK	117	120	Gene/Protein"	"MYCN	201	205	Gene/Protein"	"MYCN	260	264	Gene/Protein"	"bovine	364	370	Organism/Species"	"penicillin	422	432	Chemical/Drug"	"streptomycin	454	466	Chemical/Drug"	"[{""token"": ""neuroblastoma"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Disease/Disorder""}, {""token"": ""MYCN"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""MYCN"", ""start_span"": 201, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""MYCN"", ""start_span"": 260, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""bovine"", ""start_span"": 364, ""end_span"": 370, ""type"": ""Organism/Species""}, {""token"": ""penicillin"", ""start_span"": 422, ""end_span"": 432, ""type"": ""Chemical/Drug""}, {""token"": ""streptomycin"", ""start_span"": 454, ""end_span"": 466, ""type"": ""Chemical/Drug""}]"
Our data revealed that first, hBD3 reduced the production of interleukin - 6 ( IL - 6 ), IL - 8, monocyte chemoattractant protein - 1 ( MCP - 1 ), and macrophage migration inhibitory factor ( MIF) in HUVECs in a dose - dependent manner.	"hBD3	30	34	Gene/Protein"	"interleukin - 6	61	76	Gene/Protein"	"IL - 6	79	85	Gene/Protein"	"IL - 8	89	95	Gene/Protein"	"monocyte chemoattractant protein - 1	97	133	Gene/Protein"	"MCP - 1	136	143	Gene/Protein"	"macrophage migration inhibitory factor	151	189	Gene/Protein"	"MIF	192	195	Gene/Protein"	"[{""token"": ""hBD3"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 6"", ""start_span"": 61, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""monocyte chemoattractant protein - 1"", ""start_span"": 97, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""macrophage migration inhibitory factor"", ""start_span"": 151, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""MIF"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}]"
For vascular endothelial cells, exposure to TNF - α triggers several signaling cascades in human umbilical vein endothelial cells ( HUVECs ), especially the nuclear factor κB ( NF - κB ), c - Jun N - terminal kinase ( JNK ), and p38 mitogen - activated protein kinase pathways, leading to the production of inflammatory cytokines [ 8 ].	"TNF - α	44	51	Gene/Protein"	"human	91	96	Organism/Species"	"nuclear factor κB	157	174	Gene/Protein"	"NF - κB	177	184	Gene/Protein"	"c - Jun N - terminal kinase	188	215	Gene/Protein"	"JNK	218	221	Gene/Protein"	"p38 mitogen - activated protein kinase	229	267	Gene/Protein"	"inflammatory cytokines	307	329	Gene/Protein"	"[{""token"": ""TNF - \u03b1"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Organism/Species""}, {""token"": ""nuclear factor \u03baB"", ""start_span"": 157, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun N - terminal kinase"", ""start_span"": 188, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 218, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""p38 mitogen - activated protein kinase"", ""start_span"": 229, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""inflammatory cytokines"", ""start_span"": 307, ""end_span"": 329, ""type"": ""Gene/Protein""}]"
Then, the cells were further incubated with the indicated rabbit primary antibody at 4 ° C overnight, followed by incubation with a goat anti - rabbit secondary antibody conjugated to Alexa Fluor 488 ( for NF - κB p65) ( 1: 1000, Abcam) or Alexa Fluor 594 ( for ICAM - 1) ( 1: 1000, Abcam) for 2 h at room temperature.	"rabbit	58	64	Organism/Species"	"antibody	73	81	Gene/Protein"	"goat	132	136	Organism/Species"	"rabbit	144	150	Organism/Species"	"antibody	161	169	Gene/Protein"	"NF - κB	206	213	Gene/Protein"	"p65	214	217	Gene/Protein"	"ICAM - 1	262	270	Gene/Protein"	"[{""token"": ""rabbit"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Organism/Species""}, {""token"": ""antibody"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Organism/Species""}, {""token"": ""antibody"", ""start_span"": 161, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 206, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 262, ""end_span"": 270, ""type"": ""Gene/Protein""}]"
The downregulation of cell adhesion molecules in HUVECs by hBD3 might be mediated through inhibition of the NF - κB pathway, as the TNF - α - mediated increase in ICAM - 1 and VCAM - 1 expression is mediated through the NF - κB pathway, not the MAPK pathway [ 33 ].	"cell adhesion molecules	22	45	Gene/Protein"	"hBD3	59	63	Gene/Protein"	"NF - κB	108	115	Gene/Protein"	"TNF - α	132	139	Gene/Protein"	"ICAM - 1	163	171	Gene/Protein"	"VCAM - 1	176	184	Gene/Protein"	"NF - κB	220	227	Gene/Protein"	"MAPK	245	249	Gene/Protein"	"[{""token"": ""cell adhesion molecules"", ""start_span"": 22, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""hBD3"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 176, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 220, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 245, ""end_span"": 249, ""type"": ""Gene/Protein""}]"
Many of the known biosurfactants having bioactive potential have been reported from terrestrial habitats, the well known biosurfactants are surfactin, fengycin, bacillomycins and iturin produced by Bacillus subtilis ( Ahimou et al. 2000 ), sophorolipids ( Cavalero and Cooper 2003 ), rhamnolipids from Pseudomonas aeruginosa ( Benincasa et al. 2004) and mannosylerythritol lipids from Candida antarctica ( Arutchelvi et al. 2008 ).	"surfactin	140	149	Chemical/Drug"	"fengycin	151	159	Chemical/Drug"	"bacillomycins	161	174	Chemical/Drug"	"iturin	179	185	Chemical/Drug"	"Bacillus subtilis	198	215	Organism/Species"	"Pseudomonas aeruginosa	302	324	Organism/Species"	"mannosylerythritol	354	372	Chemical/Drug"	"Candida antarctica	385	403	Organism/Species"	"[{""token"": ""surfactin"", ""start_span"": 140, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""fengycin"", ""start_span"": 151, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""bacillomycins"", ""start_span"": 161, ""end_span"": 174, ""type"": ""Chemical/Drug""}, {""token"": ""iturin"", ""start_span"": 179, ""end_span"": 185, ""type"": ""Chemical/Drug""}, {""token"": ""Bacillus subtilis"", ""start_span"": 198, ""end_span"": 215, ""type"": ""Organism/Species""}, {""token"": ""Pseudomonas aeruginosa"", ""start_span"": 302, ""end_span"": 324, ""type"": ""Organism/Species""}, {""token"": ""mannosylerythritol"", ""start_span"": 354, ""end_span"": 372, ""type"": ""Chemical/Drug""}, {""token"": ""Candida antarctica"", ""start_span"": 385, ""end_span"": 403, ""type"": ""Organism/Species""}]"
Nicotine ’ s effect on chondrogenic differentiation was studied by exposing BMSCs to nicotine at 0. 1, 1, 10, and 100 μM, and methyllycaconitine ( MLA ), which is a selective α7 - nicotinic acetylcholine receptor ( nAChR) inhibitor and si - RNA of nuclear factor of activated T cells 2 ( NFATc2 ), were used to verify the molecular mechanism of nicotine ’ s effect.	"Nicotine	0	8	Chemical/Drug"	"nicotine	85	93	Chemical/Drug"	"methyllycaconitine	126	144	Chemical/Drug"	"α7 - nicotinic acetylcholine receptor	175	212	Gene/Protein"	"nAChR	215	220	Gene/Protein"	"nuclear factor of activated T cells 2	248	285	Gene/Protein"	"NFATc2	288	294	Gene/Protein"	"nicotine	345	353	Chemical/Drug"	"[{""token"": ""Nicotine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""methyllycaconitine"", ""start_span"": 126, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""\u03b17 - nicotinic acetylcholine receptor"", ""start_span"": 175, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""nAChR"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells 2"", ""start_span"": 248, ""end_span"": 285, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 288, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 345, ""end_span"": 353, ""type"": ""Chemical/Drug""}]"
Therefore, nicotine suppressed Sox9 by activating the Ca2 +/ calcineurin / NFATc2 signaling pathway through α7 - nAChR. Fig. 4Effects of nicotine on Sox9 and NFATc2 expression in BMSCs.	"nicotine	11	19	Chemical/Drug"	"Sox9	31	35	Gene/Protein"	"calcineurin	61	72	Gene/Protein"	"NFATc2	75	81	Gene/Protein"	"α7 - nAChR	108	118	Gene/Protein"	"nicotine	137	145	Chemical/Drug"	"Sox9	149	153	Gene/Protein"	"NFATc2	158	164	Gene/Protein"	"[{""token"": ""nicotine"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Chemical/Drug""}, {""token"": ""Sox9"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""\u03b17 - nAChR"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Chemical/Drug""}, {""token"": ""Sox9"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 158, ""end_span"": 164, ""type"": ""Gene/Protein""}]"
Data represent mean ± SEM ( n = 3 ). * p < 0. 05, ** p < 0. 01. BMSCs bone marrow mesenchymal stem cells, Col2A1 α1 chain of type II collagen, HDAC1 histone deacetylase1, MLA methyllycaconitine, NFATc2 nuclear factor of activated T cell 2, Sox9 SRY - type high - mobility group box 9	"Col2A1	106	112	Gene/Protein"	"α1 chain of type II collagen	113	141	Gene/Protein"	"HDAC1	143	148	Gene/Protein"	"histone deacetylase1	149	169	Gene/Protein"	"NFATc2	195	201	Gene/Protein"	"nuclear factor of activated T cell 2	202	238	Gene/Protein"	"Sox9	240	244	Gene/Protein"	"SRY - type high - mobility group box 9	245	283	Gene/Protein"	"[{""token"": ""Col2A1"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""\u03b11 chain of type II collagen"", ""start_span"": 113, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""HDAC1"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""histone deacetylase1"", ""start_span"": 149, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cell 2"", ""start_span"": 202, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""SRY - type high - mobility group box 9"", ""start_span"": 245, ""end_span"": 283, ""type"": ""Gene/Protein""}]"
This herbal formula is composed of the following herbs: Radix Bupleuri, Paeoniae Radix Alba, Angelica sinensis, bighead atractylodes rhizome, Poria cocos, bark of tree peony root, Fructus Gardeniae, Mentha haplocalyx, and Licorice.	"Paeoniae	72	80	Organism/Species"	"Angelica sinensis	93	110	Organism/Species"	"atractylodes	120	132	Organism/Species"	"Poria cocos	142	153	Organism/Species"	"tree peony	163	173	Organism/Species"	"Gardeniae	188	197	Organism/Species"	"Mentha haplocalyx	199	216	Organism/Species"	"Licorice	222	230	Organism/Species"	"[{""token"": ""Paeoniae"", ""start_span"": 72, ""end_span"": 80, ""type"": ""Organism/Species""}, {""token"": ""Angelica sinensis"", ""start_span"": 93, ""end_span"": 110, ""type"": ""Organism/Species""}, {""token"": ""atractylodes"", ""start_span"": 120, ""end_span"": 132, ""type"": ""Organism/Species""}, {""token"": ""Poria cocos"", ""start_span"": 142, ""end_span"": 153, ""type"": ""Organism/Species""}, {""token"": ""tree peony"", ""start_span"": 163, ""end_span"": 173, ""type"": ""Organism/Species""}, {""token"": ""Gardeniae"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Organism/Species""}, {""token"": ""Mentha haplocalyx"", ""start_span"": 199, ""end_span"": 216, ""type"": ""Organism/Species""}, {""token"": ""Licorice"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Organism/Species""}]"
The ratio of Radix Bupleuri, Paeoniae Radix Alba, Angelica sinensis, bighead atractylodes rhizome, Poria cocos, bark of tree peony root, Fructus Gardeniae, Mentha haplocalyx, and Licorice is 2: 2: 2: 2: 2: 2: 2: 1: 1.	"Paeoniae	29	37	Organism/Species"	"Angelica sinensis	50	67	Organism/Species"	"atractylodes	77	89	Organism/Species"	"Poria cocos	99	110	Organism/Species"	"tree peony	120	130	Organism/Species"	"Gardeniae	145	154	Organism/Species"	"Mentha haplocalyx	156	173	Organism/Species"	"Licorice	179	187	Organism/Species"	"[{""token"": ""Paeoniae"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Organism/Species""}, {""token"": ""Angelica sinensis"", ""start_span"": 50, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""atractylodes"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Organism/Species""}, {""token"": ""Poria cocos"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Organism/Species""}, {""token"": ""tree peony"", ""start_span"": 120, ""end_span"": 130, ""type"": ""Organism/Species""}, {""token"": ""Gardeniae"", ""start_span"": 145, ""end_span"": 154, ""type"": ""Organism/Species""}, {""token"": ""Mentha haplocalyx"", ""start_span"": 156, ""end_span"": 173, ""type"": ""Organism/Species""}, {""token"": ""Licorice"", ""start_span"": 179, ""end_span"": 187, ""type"": ""Organism/Species""}]"
These results together indicated a critical role of a functional clock to mediate NOB induction of CPS1. Fig. 6NOB restored Cps1 and Cebp mRNA and protein levels in a clock - dependent manner. a Liver samples were collected at the indicated Circadian Times ( CT) from regular chow - fed WT and Clock Δ19 / Δ19 mutant ( Clk) mice ( n = 3) in constant darkness ( DD) when the circadian clock free runs devoid of light cue.	"clock	65	70	Gene/Protein"	"CPS1	99	103	Gene/Protein"	"Cps1	124	128	Gene/Protein"	"Cebp	133	137	Gene/Protein"	"clock	167	172	Gene/Protein"	"Clock	294	299	Gene/Protein"	"mice	324	328	Organism/Species"	"clock	384	389	Gene/Protein"	"[{""token"": ""clock"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CPS1"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Cps1"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""Cebp"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""clock"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""Clock"", ""start_span"": 294, ""end_span"": 299, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 324, ""end_span"": 328, ""type"": ""Organism/Species""}, {""token"": ""clock"", ""start_span"": 384, ""end_span"": 389, ""type"": ""Gene/Protein""}]"
To determine the consequence of targeted deletions of Kmo and Haao genes on central kynurenine pathway metabolism ( Figure 1 ), cerebral levels of tryptophan and kynurenine metabolites were measured in WT, KMO −/− and HAAO −/− mice 24 h after LPS or saline administration ( Table 1 ).	"Kmo	54	57	Gene/Protein"	"Haao	62	66	Gene/Protein"	"kynurenine	84	94	Chemical/Drug"	"tryptophan	147	157	Chemical/Drug"	"kynurenine	162	172	Chemical/Drug"	"KMO	206	209	Gene/Protein"	"HAAO	218	222	Gene/Protein"	"mice	227	231	Organism/Species"	"[{""token"": ""Kmo"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Haao"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""kynurenine"", ""start_span"": 84, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""tryptophan"", ""start_span"": 147, ""end_span"": 157, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine"", ""start_span"": 162, ""end_span"": 172, ""type"": ""Chemical/Drug""}, {""token"": ""KMO"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""HAAO"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 227, ""end_span"": 231, ""type"": ""Organism/Species""}]"
Current trends show that obesity is associated with increased prevalence of adverse health conditions, including coronary heart disease, cancers ( endometrial, breast, and colon ), hypertension, stroke, dyslipidemia, type 2 diabetes, respiratory problems, and musculoskeletal conditions [ 1, 3 ].	"obesity	25	32	Disease/Disorder"	"coronary heart disease	113	135	Disease/Disorder"	"cancers	137	144	Disease/Disorder"	"hypertension	181	193	Disease/Disorder"	"stroke	195	201	Disease/Disorder"	"dyslipidemia	203	215	Disease/Disorder"	"type 2 diabetes	217	232	Disease/Disorder"	"respiratory problems	234	254	Disease/Disorder"	"[{""token"": ""obesity"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Disease/Disorder""}, {""token"": ""coronary heart disease"", ""start_span"": 113, ""end_span"": 135, ""type"": ""Disease/Disorder""}, {""token"": ""cancers"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Disease/Disorder""}, {""token"": ""hypertension"", ""start_span"": 181, ""end_span"": 193, ""type"": ""Disease/Disorder""}, {""token"": ""stroke"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Disease/Disorder""}, {""token"": ""dyslipidemia"", ""start_span"": 203, ""end_span"": 215, ""type"": ""Disease/Disorder""}, {""token"": ""type 2 diabetes"", ""start_span"": 217, ""end_span"": 232, ""type"": ""Disease/Disorder""}, {""token"": ""respiratory problems"", ""start_span"": 234, ""end_span"": 254, ""type"": ""Disease/Disorder""}]"
Using these tailored analytical methods for HIV reservoir measurements, we identified 3 ICs for which the expression on CD4 + T cells was statistically significantly associated with the frequency of CD4 + T cells harboring integrated HIV DNA, namely PD - 1, TIGIT and LAG - 3 ( Fig 1C – 1E and Table 2 ).	"HIV	44	47	Organism/Species"	"ICs	88	91	Gene/Protein"	"CD4	120	123	Gene/Protein"	"CD4	199	202	Gene/Protein"	"HIV	234	237	Organism/Species"	"PD - 1	250	256	Gene/Protein"	"TIGIT	258	263	Gene/Protein"	"LAG - 3	268	275	Gene/Protein"	"[{""token"": ""HIV"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Organism/Species""}, {""token"": ""ICs"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Organism/Species""}, {""token"": ""PD - 1"", ""start_span"": 250, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 258, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 268, ""end_span"": 275, ""type"": ""Gene/Protein""}]"
To determine the role played by ICs in each individual CD4 + T - cell memory subset, we first analyzed the expression of PD - 1, TIGIT and LAG - 3, the 3 ICs we identified to be associated with HIV persistence, on naïve ( TN ), central memory ( TCM ), transitional memory ( TTM ), effector memory ( TEM) and terminally differentiated ( TTD) cells in 48 HIV - infected participants ( Cohort 1: clinical characteristics in Table 1) ( Fig 3A, 3B and 3C respectively ).	"ICs	32	35	Gene/Protein"	"CD4	55	58	Gene/Protein"	"PD - 1	121	127	Gene/Protein"	"TIGIT	129	134	Gene/Protein"	"LAG - 3	139	146	Gene/Protein"	"ICs	154	157	Gene/Protein"	"HIV	194	197	Organism/Species"	"HIV	353	356	Organism/Species"	"[{""token"": ""ICs"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 121, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""ICs"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 353, ""end_span"": 356, ""type"": ""Organism/Species""}]"
To determine whether PD - 1, TIGIT and LAG - 3 identify cells more likely to carry persistent HIV in virally suppressed participants, individual memory CD4 + T - cell subsets were sorted based on their expression of PD - 1, TIGIT or LAG - 3 in a subset of subjects who underwent leukapheresis ( Cohort 2: clinical characteristics in Table 1) and the results were analyzed by negative binomial regression model ( S5 Table ).	"PD - 1	21	27	Gene/Protein"	"TIGIT	29	34	Gene/Protein"	"LAG - 3	39	46	Gene/Protein"	"HIV	94	97	Organism/Species"	"CD4	152	155	Gene/Protein"	"PD - 1	216	222	Gene/Protein"	"TIGIT	224	229	Gene/Protein"	"LAG - 3	233	240	Gene/Protein"	"[{""token"": ""PD - 1"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 216, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 224, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 233, ""end_span"": 240, ""type"": ""Gene/Protein""}]"
In addition, the frequency of CD4 + T cells co - expressing simultaneously PD - 1, TIGIT and LAG - 3 positively correlated with the frequency of CD4 + T cells expressing HLADR / CD38 ( p = 0. 003, r = 0. 42) and Ki67 ( p = 0. 022, r = 0. 33) ( S1D and S1E Text and S4D and S4E Fig ).	"CD4	30	33	Gene/Protein"	"PD - 1	75	81	Gene/Protein"	"TIGIT	83	88	Gene/Protein"	"LAG - 3	93	100	Gene/Protein"	"CD4	145	148	Gene/Protein"	"HLADR	170	175	Gene/Protein"	"CD38	178	182	Gene/Protein"	"Ki67	212	216	Gene/Protein"	"[{""token"": ""CD4"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""HLADR"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""CD38"", ""start_span"": 178, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""Ki67"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Gene/Protein""}]"
Expression of PD - 1, CTLA - 4, LAG - 3, TIGIT, TIM - 3, CD160 and 2B4 on CD4 + T cells in individuals receiving suppressive ART ( n = 48 ).	"PD - 1	14	20	Gene/Protein"	"CTLA - 4	22	30	Gene/Protein"	"LAG - 3	32	39	Gene/Protein"	"TIGIT	41	46	Gene/Protein"	"TIM - 3	48	55	Gene/Protein"	"CD160	57	62	Gene/Protein"	"2B4	67	70	Gene/Protein"	"CD4	74	77	Gene/Protein"	"[{""token"": ""PD - 1"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CTLA - 4"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""TIM - 3"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""CD160"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""2B4"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}]"
( D ), ( E) Associations between the frequency of CD4 + T cells co - expressing PD - 1, TIGIT and LAG - 3 and the frequencies of CD4 + T cells expression HLA - DR / CD38 and Ki67 respectively.	"CD4	50	53	Gene/Protein"	"PD - 1	80	86	Gene/Protein"	"TIGIT	88	93	Gene/Protein"	"LAG - 3	98	105	Gene/Protein"	"CD4	129	132	Gene/Protein"	"HLA - DR	154	162	Gene/Protein"	"CD38	165	169	Gene/Protein"	"Ki67	174	178	Gene/Protein"	"[{""token"": ""CD4"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DR"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""CD38"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""Ki67"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene/Protein""}]"
Absolute quantification of Bacteroides ( p =. 001 ), Closrtridium coccoides subgroup ( p = 0. 002 ), Clostridium leptum subgroup ( p = 0. 0001 ), Lactobacillus ( p = 0. 037 ), Campylobacter ( p = 0. 0014) and Eubacterium ( p = 0. 038) show significant drop in their population however, significant increase in Bifdobacterium ( p = 0. 009) was observed where as the population of Ruminococcus ( p = 0. 33) remained unaltered in healthy vs amebic patients ( E. histolytica positive ).	"Bacteroides	27	38	Organism/Species"	"Closrtridium coccoides	53	75	Organism/Species"	"Clostridium leptum	101	119	Organism/Species"	"Lactobacillus	146	159	Organism/Species"	"Campylobacter	176	189	Organism/Species"	"Eubacterium	209	220	Organism/Species"	"Bifdobacterium	310	324	Organism/Species"	"Ruminococcus	379	391	Organism/Species"	"[{""token"": ""Bacteroides"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Organism/Species""}, {""token"": ""Closrtridium coccoides"", ""start_span"": 53, ""end_span"": 75, ""type"": ""Organism/Species""}, {""token"": ""Clostridium leptum"", ""start_span"": 101, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""Lactobacillus"", ""start_span"": 146, ""end_span"": 159, ""type"": ""Organism/Species""}, {""token"": ""Campylobacter"", ""start_span"": 176, ""end_span"": 189, ""type"": ""Organism/Species""}, {""token"": ""Eubacterium"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Organism/Species""}, {""token"": ""Bifdobacterium"", ""start_span"": 310, ""end_span"": 324, ""type"": ""Organism/Species""}, {""token"": ""Ruminococcus"", ""start_span"": 379, ""end_span"": 391, ""type"": ""Organism/Species""}]"
Primers Nim - F and Nim - R designed by us amplify all the members of nim gene family viz. nimA, nimB, nimC, nimD and nimE.	"Nim	8	11	Gene/Protein"	"Nim	20	23	Gene/Protein"	"nim	70	73	Gene/Protein"	"nimA	91	95	Gene/Protein"	"nimB	97	101	Gene/Protein"	"nimC	103	107	Gene/Protein"	"nimD	109	113	Gene/Protein"	"nimE	118	122	Gene/Protein"	"[{""token"": ""Nim"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""Nim"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""nim"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""nimA"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""nimB"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""nimC"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""nimD"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""nimE"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}]"
For example, vitamin B12, vitamin B6, riboflavin, methionine, choline and betaine, well known as folates, regulate levels of S - adenosylmethionine and S - adenosylhomocysteine, donor of - CH3 group and methyltransferase inhibitor respectively [ 71 ].	"vitamin B12	13	24	Chemical/Drug"	"vitamin B6	26	36	Chemical/Drug"	"riboflavin	38	48	Chemical/Drug"	"methionine	50	60	Chemical/Drug"	"choline	62	69	Chemical/Drug"	"betaine	74	81	Chemical/Drug"	"folates	97	104	Chemical/Drug"	"methyltransferase	203	220	Gene/Protein"	"[{""token"": ""vitamin B12"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin B6"", ""start_span"": 26, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""riboflavin"", ""start_span"": 38, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""methionine"", ""start_span"": 50, ""end_span"": 60, ""type"": ""Chemical/Drug""}, {""token"": ""choline"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""betaine"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""folates"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""methyltransferase"", ""start_span"": 203, ""end_span"": 220, ""type"": ""Gene/Protein""}]"
We cloned two cDNAs from soybean ( Glycine max ), GmPT1 and GmPT2, which show homology to the phosphate / proton cotransporter PHO84 from the budding yeast Saccharomyces cerevisiae.	"soybean	25	32	Organism/Species"	"Glycine max	35	46	Organism/Species"	"GmPT1	50	55	Gene/Protein"	"GmPT2	60	65	Gene/Protein"	"phosphate / proton cotransporter	94	126	Gene/Protein"	"PHO84	127	132	Gene/Protein"	"yeast	150	155	Organism/Species"	"Saccharomyces cerevisiae	156	180	Organism/Species"	"[{""token"": ""soybean"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""Glycine max"", ""start_span"": 35, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""GmPT1"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""phosphate / proton cotransporter"", ""start_span"": 94, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""PHO84"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""yeast"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Organism/Species""}, {""token"": ""Saccharomyces cerevisiae"", ""start_span"": 156, ""end_span"": 180, ""type"": ""Organism/Species""}]"
A clear GFP signal was observed at the periphery of cells bombarded with the GmPT1 / GFP or GmPT2 / GFP construction ( Figure 4A – C and G – I for GmPT1 and GmPT2, respectively ), whereas the signal was seen throughout cells expressing free GFP ( Figure 4D – F ).	"GFP	8	11	Gene/Protein"	"GmPT1	77	82	Gene/Protein"	"GFP	85	88	Gene/Protein"	"GmPT2	92	97	Gene/Protein"	"GFP	100	103	Gene/Protein"	"GmPT1	147	152	Gene/Protein"	"GmPT2	157	162	Gene/Protein"	"GFP	241	244	Gene/Protein"	"[{""token"": ""GFP"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""GmPT1"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""GmPT1"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 241, ""end_span"": 244, ""type"": ""Gene/Protein""}]"
Phylogenetically, the Pi transporters in plants and fungi belong to a closely related family, even though the similarity between the plant transporters is significantly higher than that between plants and fungi transporters [ 14 ].	"Pi transporters	22	37	Gene/Protein"	"plants	41	47	Organism/Species"	"fungi	52	57	Organism/Species"	"plant	133	138	Organism/Species"	"transporters	139	151	Gene/Protein"	"plants	194	200	Organism/Species"	"fungi	205	210	Organism/Species"	"transporters	211	223	Gene/Protein"	"[{""token"": ""Pi transporters"", ""start_span"": 22, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Organism/Species""}, {""token"": ""fungi"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Organism/Species""}, {""token"": ""transporters"", ""start_span"": 139, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 194, ""end_span"": 200, ""type"": ""Organism/Species""}, {""token"": ""fungi"", ""start_span"": 205, ""end_span"": 210, ""type"": ""Organism/Species""}, {""token"": ""transporters"", ""start_span"": 211, ""end_span"": 223, ""type"": ""Gene/Protein""}]"
A PCR - generated Xba I – BamH I fragment containing the open reading frame of GmPT1 and the Xba I – Xba I fragment containing the open reading frame of GmPT2 were subcloned in - frame upstream of the GFP gene in plasmid pBI - 121 - GFP.	"Xba I	18	23	Gene/Protein"	"BamH I	26	32	Gene/Protein"	"GmPT1	79	84	Gene/Protein"	"Xba I	93	98	Gene/Protein"	"Xba I	101	106	Gene/Protein"	"GmPT2	153	158	Gene/Protein"	"GFP	201	204	Gene/Protein"	"GFP	233	236	Gene/Protein"	"[{""token"": ""Xba I"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""BamH I"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""GmPT1"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""Xba I"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Xba I"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Gene/Protein""}]"
While homologs of DGK - κ were mainly found in mammals, birds and some fishes and reptiles, homologs of DGK - γ were not detected in fishes and amphibians.	"DGK - κ	18	25	Gene/Protein"	"mammals	47	54	Organism/Species"	"birds	56	61	Organism/Species"	"fishes	71	77	Organism/Species"	"reptiles	82	90	Organism/Species"	"DGK - γ	104	111	Gene/Protein"	"fishes	133	139	Organism/Species"	"amphibians	144	154	Organism/Species"	"[{""token"": ""DGK - \u03ba"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""mammals"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Organism/Species""}, {""token"": ""fishes"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Organism/Species""}, {""token"": ""reptiles"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Organism/Species""}, {""token"": ""DGK - \u03b3"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""fishes"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Organism/Species""}, {""token"": ""amphibians"", ""start_span"": 144, ""end_span"": 154, ""type"": ""Organism/Species""}]"
Each of the three NTFs ( NGF, NT3, and BDNF) were encapsulated in microspheres as previously described [ 51] and added to a collagen solution to reach a final concentration of 2 µg / mL for BDNF and 1 µg / mL for NGF and NT3 respectively.	"NTFs	18	22	Gene/Protein"	"NGF	25	28	Gene/Protein"	"NT3	30	33	Gene/Protein"	"BDNF	39	43	Gene/Protein"	"collagen	124	132	Gene/Protein"	"BDNF	190	194	Gene/Protein"	"NGF	213	216	Gene/Protein"	"NT3	221	224	Gene/Protein"	"[{""token"": ""NTFs"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""collagen"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 213, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 221, ""end_span"": 224, ""type"": ""Gene/Protein""}]"
A sequence search using a conserved carboxylate transporter signature of JEN family, NXXS / THXS / TQDXXXT, identified six putative proteins encoded by the YALI0B19470g, YALI0C15488g, YALI0C21406g, YALI0D24607g, YALI0D20108g, and YALI0E32901g genes, which exhibited high similarity to the signature sequence.	"carboxylate transporter	36	59	Gene/Protein"	"JEN	73	76	Gene/Protein"	"YALI0B19470g	156	168	Gene/Protein"	"YALI0C15488g	170	182	Gene/Protein"	"YALI0C21406g	184	196	Gene/Protein"	"YALI0D24607g	198	210	Gene/Protein"	"YALI0D20108g	212	224	Gene/Protein"	"YALI0E32901g	230	242	Gene/Protein"	"[{""token"": ""carboxylate transporter"", ""start_span"": 36, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""JEN"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""YALI0B19470g"", ""start_span"": 156, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C15488g"", ""start_span"": 170, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C21406g"", ""start_span"": 184, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D24607g"", ""start_span"": 198, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D20108g"", ""start_span"": 212, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""YALI0E32901g"", ""start_span"": 230, ""end_span"": 242, ""type"": ""Gene/Protein""}]"
After individual transportation of each endogenous transporters gene into cells of parental strain, relative changes of 2. 54 ± 0. 22 - fold for YALI0B19470g, 2. 33 ± 0. 27 - fold for YALI0C15488g, 2. 62 ± 0. 33 - fold for YALI0C21406g, 2. 28 ± 0. 19 - fold for YALI0D24607g, 2. 39 ± 0. 26 - fold for YALI0D20108g and 2. 55 ± 0. 32 - fold for YALI0E32901g were observed, which indicated one more copy of each transporter gene existed per genome in corresponding recombinant strain ( Fig. 6 ).	"transporters	51	63	Gene/Protein"	"YALI0B19470g	145	157	Gene/Protein"	"YALI0C15488g	184	196	Gene/Protein"	"YALI0C21406g	223	235	Gene/Protein"	"YALI0D24607g	262	274	Gene/Protein"	"YALI0D20108g	301	313	Gene/Protein"	"YALI0E32901g	343	355	Gene/Protein"	"transporter	409	420	Gene/Protein"	"[{""token"": ""transporters"", ""start_span"": 51, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""YALI0B19470g"", ""start_span"": 145, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C15488g"", ""start_span"": 184, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""YALI0C21406g"", ""start_span"": 223, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D24607g"", ""start_span"": 262, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""YALI0D20108g"", ""start_span"": 301, ""end_span"": 313, ""type"": ""Gene/Protein""}, {""token"": ""YALI0E32901g"", ""start_span"": 343, ""end_span"": 355, ""type"": ""Gene/Protein""}, {""token"": ""transporter"", ""start_span"": 409, ""end_span"": 420, ""type"": ""Gene/Protein""}]"
Yeast strains were cultured in YPD medium ( 10 g · L − 1yeast extract, 20 g · L − 1 peptone, and 20 g · L − 1 dextrose) or YNB medium ( 20 g · L − 1 glucose, 1. 7 g · L − 1 yeast nitrogen base without amino acids, 5 g · L − 1 ( NH4) 2SO4) supplemented with 50 μg · mL − 1 uracil, leucine, tryptophan and histidine when necessary.	"Yeast	0	5	Organism/Species"	"glucose	149	156	Chemical/Drug"	"yeast	173	178	Organism/Species"	"amino acids	201	212	Chemical/Drug"	"uracil	272	278	Chemical/Drug"	"leucine	280	287	Chemical/Drug"	"tryptophan	289	299	Chemical/Drug"	"histidine	304	313	Chemical/Drug"	"[{""token"": ""Yeast"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism/Species""}, {""token"": ""glucose"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Chemical/Drug""}, {""token"": ""yeast"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Organism/Species""}, {""token"": ""amino acids"", ""start_span"": 201, ""end_span"": 212, ""type"": ""Chemical/Drug""}, {""token"": ""uracil"", ""start_span"": 272, ""end_span"": 278, ""type"": ""Chemical/Drug""}, {""token"": ""leucine"", ""start_span"": 280, ""end_span"": 287, ""type"": ""Chemical/Drug""}, {""token"": ""tryptophan"", ""start_span"": 289, ""end_span"": 299, ""type"": ""Chemical/Drug""}, {""token"": ""histidine"", ""start_span"": 304, ""end_span"": 313, ""type"": ""Chemical/Drug""}]"
Main outcomes of interest were incident cardiovascular disease ( myocardial infarction, angina pectoris, heart failure, stroke or transient ischemic attack, and peripheral arterial disease ), cardiovascular mortality and overall mortality, and changes in cardiovascular risk factors including blood pressure ( BP ), glycated hemoglobin A1c ( HbA1c ), low - density lipoprotein ( LDL) cholesterol, smoking status, weight, level of physical exercise, or a composite cardiovascular risk score.	"cardiovascular disease	40	62	Disease/Disorder"	"myocardial infarction	65	86	Disease/Disorder"	"heart failure	105	118	Disease/Disorder"	"stroke	120	126	Disease/Disorder"	"transient ischemic attack	130	155	Disease/Disorder"	"peripheral arterial disease	161	188	Disease/Disorder"	"hemoglobin	325	335	Gene/Protein"	"cholesterol	384	395	Chemical/Drug"	"[{""token"": ""cardiovascular disease"", ""start_span"": 40, ""end_span"": 62, ""type"": ""Disease/Disorder""}, {""token"": ""myocardial infarction"", ""start_span"": 65, ""end_span"": 86, ""type"": ""Disease/Disorder""}, {""token"": ""heart failure"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Disease/Disorder""}, {""token"": ""stroke"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Disease/Disorder""}, {""token"": ""transient ischemic attack"", ""start_span"": 130, ""end_span"": 155, ""type"": ""Disease/Disorder""}, {""token"": ""peripheral arterial disease"", ""start_span"": 161, ""end_span"": 188, ""type"": ""Disease/Disorder""}, {""token"": ""hemoglobin"", ""start_span"": 325, ""end_span"": 335, ""type"": ""Gene/Protein""}, {""token"": ""cholesterol"", ""start_span"": 384, ""end_span"": 395, ""type"": ""Chemical/Drug""}]"
a Abbreviations: BMI: body mass index; CHD: coronary heart disease; CVD: cardiovascular disease; DM: diabetes mellitus; DM2: type 2 diabetes mellitus; LDL: low - density lipoprotein.	"CHD	39	42	Disease/Disorder"	"coronary heart disease	44	66	Disease/Disorder"	"CVD	68	71	Disease/Disorder"	"cardiovascular disease	73	95	Disease/Disorder"	"DM	97	99	Disease/Disorder"	"diabetes mellitus	101	118	Disease/Disorder"	"DM2	120	123	Disease/Disorder"	"type 2 diabetes mellitus	125	149	Disease/Disorder"	"[{""token"": ""CHD"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Disease/Disorder""}, {""token"": ""coronary heart disease"", ""start_span"": 44, ""end_span"": 66, ""type"": ""Disease/Disorder""}, {""token"": ""CVD"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Disease/Disorder""}, {""token"": ""cardiovascular disease"", ""start_span"": 73, ""end_span"": 95, ""type"": ""Disease/Disorder""}, {""token"": ""DM"", ""start_span"": 97, ""end_span"": 99, ""type"": ""Disease/Disorder""}, {""token"": ""diabetes mellitus"", ""start_span"": 101, ""end_span"": 118, ""type"": ""Disease/Disorder""}, {""token"": ""DM2"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Disease/Disorder""}, {""token"": ""type 2 diabetes mellitus"", ""start_span"": 125, ""end_span"": 149, ""type"": ""Disease/Disorder""}]"
